New cancer clinical trial: Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

Published on: March 01, 2018 at 12:00PM
Condition:   Breast Cancer
Intervention:   Drug: DHES0815A
Sponsor:   Genentech, Inc.
Recruiting
http://ift.tt/2GZ1rbT